EUVIMEDEUVIMED entdecken
Metaanalyse

The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis

Marta Infante-Cano, Cristina García-Muñoz, Javier Matias-Soto iD, Saul Pineda-Escobar, Olga Villar-Alises, Javier Martinez-Calderon iD

Archives of Women's Mental Health · 2025-06 · 28 (3) · 475-489

DOI: 10.1007/s00737-024-01526-1 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Archives of Women's Mental Health, online erschienen am 25.10.2024. Verfasst von Marta Infante-Cano und 5 weiteren Autor:innen. Beteiligte Einrichtung: CTS 1110: Understanding Movement and Self in Health From Science (UMSS) Research Group, Andalusia, Spain. Hauptthemen laut MEDLINE: Anxiety, Anxiety Disorders, Depression, Depressive Disorder. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To summarize the pooled prevalence rates of anxiety and depression in women with polycystic ovary syndrome. METHODS: An overview of systematic reviews with meta-analysis was conducted. The CINAHL, Embase, PsycINFO, and PubMed databases were searched up to April 22, 2024. The methodological quality of systematic reviews was assessed using AMSTAR 2. The degree of overlap between reviews was analyzed by calculating the corrected covered area. RESULTS: Ten systematic reviews were selected. Regarding anxiety disorders, the pooled prevalence of panic disorder, social phobia, and anxiety disorders without specifying the type of disorder were 4%, 5%, and 16.9%, respectively. This prevalence was higher in depressive disorders, reaching 34.8%. Anxiety symptoms were very prevalent in women with PCOS, although the prevalence varied depending on the self-reported questionnaire used: the Hamilton Anxiety Scale 69.4%, the Hospital Anxiety and Depression Scale 41.5%, and the Self-rating Anxiety Scale 32.4%. Additionally, the highest prevalence of depression symptoms was associated with the Beck Depression Inventory 46.0%, followed by the Self-rating Depression Scale 39.2%, and the Hospital Anxiety and Depression Scale, which ranged from 31% to 33.8%. CONCLUSIONS: Meta-analyses found mainly anxiety and depression symptoms and disorders are prevalent in women with PCOS. Meta-analyses also showed women with PCOS had a higher risk of having anxiety disorders, and depression symptoms than women without PCOS. HIGHLIGHTS: • Anxiety symptoms were prevalent, although the prevalence varied depending on the self-reported questionnaire. • The highest prevalence of depression symptoms was associated with the Beck Depression Inventory (46.0%). • The pooled prevalence of anxiety disorders without specifying the type of disorder was 16.9%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnxietyAnxiety DisordersDepressionDepressive DisorderPolycystic Ovary SyndromeAdultFemaleHumansPrevalencePsychiatric Status Rating ScalesSystematic Reviews as Topic

Stichwörter der Autor:innen

AnxietyDepressionOverviewPolycystic ovary syndromePrevalenceSystematic review

Autor:innen und Institutionen

  • CTS 1110: Understanding Movement and Self in Health From Science (UMSS) Research Group, Andalusia, Spain.
  • Universidad Loyola de Andalucía, Seville, Spain.
  • CTS 1110: Understanding Movement and Self in Health From Science (UMSS) Research Group, Andalusia, Spain. msjavi93@gmail.com.
  • Universidad Loyola de Andalucía, Seville, Spain. msjavi93@gmail.com.
  • Faculty of Health Sciences, Department of Physical Therapy, Universidad de Malaga, Malaga, Spain. msjavi93@gmail.com.
  • Department of Physiotherapy, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, 41009, Seville, Spain.

ORCID-Profile: Javier Matias-Soto, Javier Martinez-Calderon

Zitieren

APA

Infante-Cano, M., García-Muñoz, C., Matias-Soto, J., Pineda-Escobar, S., Villar-Alises, O., & Martinez-Calderon, J. (2025). The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis. Archives of Women's Mental Health, 28(3), 475-489. https://doi.org/10.1007/s00737-024-01526-1

Vancouver

Infante-Cano M, García-Muñoz C, Matias-Soto J, Pineda-Escobar S, Villar-Alises O, Martinez-Calderon J. The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis. Archives of Women's Mental Health. 2025;28(3):475-489. doi:10.1007/s00737-024-01526-1

BibTeX
@article{InfanteCano2025,
  author = {Infante-Cano, Marta and García-Muñoz, Cristina and Matias-Soto, Javier and Pineda-Escobar, Saul and Villar-Alises, Olga and Martinez-Calderon, Javier},
  title = {The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis},
  journal = {Archives of Women's Mental Health},
  year = {2025},
  volume = {28},
  number = {3},
  pages = {475--489},
  doi = {10.1007/s00737-024-01526-1}
}
Kostenlos starten →